Effect of corticosteroid dosing on outcomes in high-grade immune checkpoint inhibitor hepatitis.
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology"
DOI: 10.1002/hep.32215
Abstract: BACKGROUND AND AIMS Consensus guidelines recommend high-dose corticosteroids (1-2 mg/kg/day methylprednisolone equivalents) for treating grade ≥3 immune checkpoint inhibitor (ICI) hepatitis. We examined the effect of corticosteroid dosing on time to alanine aminotransferase (ALT) normalization,… read more here.
Keywords: grade immune; immune checkpoint; corticosteroid; grade ... See more keywords
P08.02.B HIGH-GRADE IMMUNE-RELATED ADVERSE EVENTS AND PATIENT OUTCOMES FOLLOWING POST-OPERATIVE CHECKPOINT INHIBITION IN RESECTED BRAIN METASTASES: A RETROSPECTIVE COHORT STUDY
Sign Up to like & getrecommendations! Published in 2025 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noaf193.270
Abstract: Immune checkpoint inhibitors (ICIs) are increasingly used in patients with brain metastases, yet their postoperative safety and efficacy remain unclear. This study evaluates survival outcomes and high-grade immune-related adverse events (irAEs) in patients receiving ICIs… read more here.
Keywords: brain; brain metastases; high grade; grade immune ... See more keywords